Sutro Biopharma Inc.
News
Sutro Biopharma to Host Research Forum Highlighting Next-Generation ADC Innovation and Near-term Pipeline, on October 10, 2024
Globe Newswire SOUTH SAN FRANCISCO, Calif., Sept. 11, 2024 (GLOBE NEWSWIRE) -- Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), a clinical-stage oncology company pioneering site-specific and...\n more…
Sutro Biopharma, Inc. (NASDAQ:STRO) Shares Purchased by Panagora Asset Management Inc.
Ticker Report Panagora Asset Management Inc. grew its position in shares of Sutro Biopharma, Inc. (NASDAQ:STRO - Free Report) by 15.6% during the second quarter, Holdings Channel reports. The firm owned 907,503...\n more…
SG Americas Securities LLC Sells 6,421 Shares of Sutro Biopharma, Inc. (NASDAQ:STRO)
Ticker Report SG Americas Securities LLC decreased its holdings in Sutro Biopharma, Inc. (NASDAQ:STRO - Free Report) by 30.3% in the second quarter, according to the company in its most recent 13F filing with the...\n more…
Sutro Biopharma, Inc. (NASDAQ:STRO) Receives Consensus Recommendation of "Buy" from Brokerages
Zolmax Sutro Biopharma, Inc. (NASDAQ:STRO - Get Free Report) has been given a consensus recommendation of "Buy" by the eight analysts that are presently covering the company, MarketBeat Ratings reports...\n more…
There's No Escaping Sutro Biopharma, Inc.'s (NASDAQ:STRO) Muted Revenues Despite A 29% Share Price Rise
Simply Wall St Sutro Biopharma, Inc. ( NASDAQ:STRO ) shares have had a really impressive month, gaining 29% after a shaky period...\n more…
Brokerages Set Sutro Biopharma, Inc. (NASDAQ:STRO) Target Price at $12.13
Ticker Report Sutro Biopharma, Inc. (NASDAQ:STRO - Get Free Report) has been given a consensus rating of "Buy" by the eight ratings firms that are presently covering the firm, MarketBeat reports. Eight equities...\n more…